Male Infertility, Precision Medicine and Systems Proteomics.

Niloofar Agharezaee, Mehrdad Hashemi, Minoo Shahani, Kambiz Gilany
Author Information
  1. Niloofar Agharezaee: Department of Genetics, Faculty of Advanced Science and Technology, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran.
  2. Mehrdad Hashemi: Department of Genetics, Faculty of Advanced Science and Technology, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran.
  3. Minoo Shahani: Faculty of Advanced Science and Technology, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran.
  4. Kambiz Gilany: Reproductive Biotechnology Research Center, Avicenna Research Institute, ACECR, Tehran, Iran.

Abstract

Precision medicine (PM) is an approach that has the power to create the best effect and safety of medicine and treatment with the least side effects for each person. PM is very helpful as sometimes due to inaccurate or late diagnosis or toxicities of the drugs irreversible side effect for patient's health are generated. This seemingly new and emerging science is also effective in preventing disease, due to differences in the genes, environment, and lifestyles of any particular person. PM can be a prominent criterion in infertility research. To achieve this goal, there should be information from a healthy human body, including genetic and molecular information. A PM is an evolution in health care, which is very helpful even economically. The guarantor of the PM success is the examination of the molecular profile of the patient, including genes, proteins, metabolites, . Therefore, genomics, proteomics, and metabolomics-based techniques are very important in this regard. Unfortunately, despite extensive studies on PM practice in various fields, male infertility has remained unresponsive. Given that around 20% of couples around the world suffer from infertility, and almost half of them are related to men's problems, the PM approach has a high potential for male infertility. In this study, with the help of proteomics and metabolomics, PM information on male infertility was explored.

Keywords

References

  1. BMJ. 2000 Sep 30;321(7264):789-92 [PMID: 11009515]
  2. Harv Bus Rev. 2007 Oct;85(10):108-17, 165 [PMID: 17972499]
  3. Biotechniques. 2009 Apr;46(5):351-2, 354-5 [PMID: 19480630]
  4. Am J Epidemiol. 2009 Sep 1;170(5):559-65 [PMID: 19635736]
  5. Clin Chem. 2010 Feb;56(2):177-85 [PMID: 19884488]
  6. Reprod Biomed Online. 2010 Jun;20(6):711-23 [PMID: 20378409]
  7. Hum Reprod. 2011 Jul;26(7):1628-40 [PMID: 21546386]
  8. Fertil Steril. 2013 Mar 15;99(4):998-1007 [PMID: 23415969]
  9. Mol Reprod Dev. 2013 May;80(5):350-7 [PMID: 23559416]
  10. Semin Reprod Med. 2013 Jul;31(4):293-300 [PMID: 23775385]
  11. Mol Reprod Dev. 2014 Jan;81(1):84-6 [PMID: 24254375]
  12. Reprod Biomed Online. 2013 Dec;27(6):611-23 [PMID: 24449934]
  13. J Endocrinol Invest. 2014 May;37(5):415-27 [PMID: 24458834]
  14. Avicenna J Med Biotechnol. 2014 Jan;6(1):47-52 [PMID: 24523955]
  15. Cent European J Urol. 2013;66(1):60-7 [PMID: 24578993]
  16. Cochrane Database Syst Rev. 2014;(12):CD007411 [PMID: 25504418]
  17. N Engl J Med. 2015 Feb 26;372(9):793-5 [PMID: 25635347]
  18. Curr Opin Biotechnol. 2015 Aug;34:162-70 [PMID: 25636126]
  19. Mol Reprod Dev. 2015 Mar;82(3):150 [PMID: 25676838]
  20. J Reprod Infertil. 2015 Apr-Jun;16(2):61-71 [PMID: 25927022]
  21. N Engl J Med. 2015 Jun 4;372(23):2229-34 [PMID: 26014593]
  22. Discov Med. 2015 Jun;19(107):471-7 [PMID: 26175405]
  23. Am J Mens Health. 2017 Jul;11(4):1124-1129 [PMID: 26186950]
  24. Brief Bioinform. 2016 May;17(3):494-504 [PMID: 26249224]
  25. Health Prog. 2015 Sep-Oct;96(5):74-6 [PMID: 26437494]
  26. Andrologia. 2016 Aug;48(6):609-16 [PMID: 26608970]
  27. Fertil Steril. 2016 Mar;105(3):629-636 [PMID: 26674559]
  28. Expert Rev Mol Diagn. 2016 Jul;16(7):719-22 [PMID: 26959799]
  29. Cryo Letters. 2016 Jan-Feb;37(1):34-40 [PMID: 26964023]
  30. Asian J Androl. 2016 May-Jun;18(3):426-33 [PMID: 26975492]
  31. EBioMedicine. 2016 Feb 08;4:24-5 [PMID: 26981568]
  32. Cell. 2016 Apr 21;165(3):535-50 [PMID: 27104977]
  33. Clin Chim Acta. 2017 Apr;467:51-58 [PMID: 27265523]
  34. Healthc Manage Forum. 2016 Jul;29(4):158-61 [PMID: 27278139]
  35. Eur Urol. 2016 Dec;70(6):924-925 [PMID: 27417032]
  36. Hastings Cent Rep. 2016 Sep;46(5):21-33 [PMID: 27649826]
  37. Genomics Proteomics Bioinformatics. 2016 Oct;14(5):253-261 [PMID: 27744061]
  38. Proteomes. 2016;4(4): [PMID: 27882306]
  39. Trends Pharmacol Sci. 2017 Jan;38(1):1-2 [PMID: 27955860]
  40. Clin Pharmacol Ther. 2017 Mar;101(3):359-367 [PMID: 27984650]
  41. Biomed Chromatogr. 2017 Aug;31(8):null [PMID: 28058728]
  42. Int J Reprod Biomed (Yazd). 2016 Dec;14(12):729-736 [PMID: 28066832]
  43. Urol J. 2017 Jan 18;14(1):2973-2978 [PMID: 28116742]
  44. HSS J. 2017 Feb;13(1):20-27 [PMID: 28167869]
  45. Daru. 2017 Apr 4;25(1):7 [PMID: 28372571]
  46. Genomics Proteomics Bioinformatics. 2017 Apr;15(2):57-58 [PMID: 28392478]
  47. J Assist Reprod Genet. 2017 Aug;34(8):967-973 [PMID: 28470451]
  48. Nat Rev Urol. 2017 Aug;14(8):470-485 [PMID: 28508879]
  49. Indian J Urol. 2017 Jul-Sep;33(3):207-214 [PMID: 28717270]
  50. Clin Transl Med. 2017 Dec;6(1):23 [PMID: 28744848]
  51. Trans Am Clin Climatol Assoc. 2017;128:160-168 [PMID: 28790500]
  52. Adv Exp Med Biol. 2017;1007:59-70 [PMID: 28840552]
  53. Proteomics Clin Appl. 2018 Mar;12(2): [PMID: 28980455]
  54. J Pers Med. 2017 Oct 16;7(4):null [PMID: 29035320]
  55. Brief Bioinform. 2017 Oct 25;:null [PMID: 29077790]
  56. Ir J Med Sci. 2018 Aug;187(3):657-662 [PMID: 29143242]
  57. Q Rev Biophys. 1997 Nov;30(4):279-331 [PMID: 9634650]

Word Cloud

Created with Highcharts 10.0.0PMinfertilityPrecisionmedicineinformationmaleapproacheffectsidepersonhelpfulduehealthgenesincludingmolecularproteomicsaroundMaleInfertilityProteomicspowercreatebestsafetytreatmentleasteffectssometimesinaccuratelatediagnosistoxicitiesdrugsirreversiblepatient'sgeneratedseeminglynewemergingsciencealsoeffectivepreventingdiseasedifferencesenvironmentlifestylesparticularcanprominentcriterionresearchachievegoalhealthyhumanbodygeneticevolutioncareeveneconomicallyguarantorsuccessexaminationprofilepatientproteinsmetabolitesThereforegenomicsmetabolomics-basedtechniquesimportantregardUnfortunatelydespiteextensivestudiespracticevariousfieldsremainedunresponsiveGiven20%couplesworldsufferalmosthalfrelatedmen'sproblemshighpotentialstudyhelpmetabolomicsexploredMedicineSystems

Similar Articles

Cited By